INNOVATIVE EXTRACORPOREAL TECHNOLOGIES


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper presents the classification of extracorporeal techniques according to their level of selectivity. Current selective and specific extracorporeal technologies are characterized; their advantages and disadvantages are described. Selective and specific extracorporeal technologies can be designed if it is precisely known that target-removed molecules or blood cells play a key role in the pathogenesis of the disease. Their introduction is reasonable if it leads to the increased efficiency and safety of extracorporeal treatment.

全文:

受限制的访问

作者简介

A. Sokolov

I.I. Mechnikov North-Western State Medical University

Email: dr.sokolov@list.ru
Professor

参考

  1. Соколов А.А. Современные экстракорпоральные технологии: каскадная плазмофильтрация / СПб, 2013; 60 с.
  2. van Buuren F., Kreickmann S., Horstkotte D. et al. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures // Clin. Res. Cardiol. Suppl. - 2012; 7: 24-30.
  3. Hirata N., Kuriyama T., Yamawaki N. Immusorba TR and PH // Ther. Apher. Dial. - 2003; 7 (1): 85-90.
  4. Wu F., Heng K., Salleh R. et al. Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus // Transfus. Apher. Sci. - 2012; 47 (3): 345-50.
  5. Cancelas J., Padmanabhan A., Le T. et al. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial // Transfusion. - 2015; 55 (4): 748-55.
  6. Leitner G., Worel N., Vogelsang H. Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease // Transfus. Med. Hemother. - 2012; 39 (4): 246-52.
  7. Афанасьева О.И., Алтынова Е.В., Соколов А.А. и др. Сравнительный анализ эффективности и специфичности разных сорбентов для афереза липопротеидов низкой плотности // Бюлл. эксперимент. биол. и медицины. -2006; 142 (11): 532-7.
  8. Rönspeck W., Brinckmann R., Egner R. et al. Peptide based adsorbers for therapeutic immunoadsorption // Ther. Apher. Dial. - 2003; 7 (1): 91-7.
  9. Mock U., Nickolay L., Philip B. et al. Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy // Cytotherapy. - 2016; 18 (8): 1002-11.
  10. Poullin P., Announ N., Mugnier B. et al. Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis // Joint Bone Spine. -2005; 72 (2): 101-3.
  11. Мануилов А.С., Бардаков С.Н., Соколов А.А. и др. Сравнительная оценка динамики концентрации иммуноглобулинов при каскадной плазмофильтрации и иммуносорбции с регенерацией сорбционных колонок. Лечебный гемаферез и экстракорпоральная гемокоррекция: достижения и надежды. -Тезисы докл. III Конф. национальн. общ. спец. в обл. гемафереза и экстракорп. гемокор. СПб, 2017; с. 60-1.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2022
##common.cookie##